润都股份: 关于持股5%以上股东减持股份预披露的公告

Core Viewpoint - The major shareholder of Zhuhai Runduo Pharmaceutical Co., Ltd., Mr. Li Xi, plans to reduce his shareholding by up to 10,046,797 shares, representing 3% of the company's total share capital, within a specified period from August 11, 2025, to November 10, 2025 [1][2]. Group 1: Shareholder Information - Mr. Li Xi holds 100,865,992 shares, accounting for 30.12% of the company's total share capital, while his concerted actor, Mr. Chen Xinmin, holds 100,865,992 shares, representing 55.67% of the total share capital [1][2]. - The reduction plan includes a maximum of 3,348,932 shares through centralized bidding (1% of total share capital) and up to 6,697,865 shares through block trading (2% of total share capital) [1][2]. Group 2: Reduction Plan Details - The reduction plan is set to take place within three months following the announcement, specifically from August 11, 2025, to November 10, 2025 [1][2]. - The number of shares to be reduced may be adjusted in case of any changes in the company's share structure, such as stock dividends or capital increases [2]. Group 3: Shareholder Commitments - Mr. Li Xi has made commitments to avoid transferring benefits to other entities or individuals unfairly and to adhere to the company's budget management [2][3]. - He has also committed to not engaging in competitive businesses with the company during his tenure and to compensate the company for any losses incurred due to violations of these commitments [3][4].